AORT Form 144 details 6,394-share planned sale and recent trades

Rhea-AI Filing Summary

Artivion, Inc. (AORT)6,394 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $288,816.98. These shares were acquired on 11/17/2025 through the cash exercise of an employee stock option originally granted on 03/05/2019. The filing notes that 47,374,939 common shares were outstanding. Over the prior three months, the same seller, Jean F. Holloway, reported selling additional common shares in three transactions totaling 22,154 shares for gross proceeds of $1,013,674.66.

11/17/2025 - 12:04 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6394	288816.98	47374939	11/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/17/2025	Option Granted- 03/05/2019	Issuer			6394	11/17/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jean F. Holloway 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/11/2025	10000	461800.00
Jean F. Holloway 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/13/2025	5761	264189.66
Jean F. Holloway 1655 Roberts Boulevard Kennesaw GA 30144	Common	11/14/2025	6393	287685.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for AORT disclose?

The Form 144 discloses that a shareholder intends to sell 6,394 shares of Artivion common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value listed as $288,816.98.

Who is selling Artivion (AORT) shares and how many were recently sold?

Jean F. Holloway is the named seller. In addition to the planned sale of 6,394 shares, the filing reports prior sales over the past three months totaling 22,154 common shares for gross proceeds of $1,013,674.66.

How were the AORT shares being sold under Form 144 acquired?

The 6,394 common shares covered by the notice were acquired on 11/17/2025 via a stock option exercise described as “Option Granted- 03/05/2019”, with the exercise paid in cash.

How many Artivion (AORT) shares are outstanding according to the filing?

The filing states that there were 47,374,939 shares of common stock outstanding at the time referenced, providing context for the size of the planned sale.

What past 3-month Artivion share sales are reported in the Form 144?

The notice lists three prior sales by Jean F. Holloway: 10,000 shares on 11/11/2025 for $461,800.00, 5,761 shares on 11/13/2025 for $264,189.66, and 6,393 shares on 11/14/2025 for $287,685.00.

What representation does the seller make in the AORT Form 144 notice?

The seller represents by signing that they do not know any material adverse information regarding the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements.